Literature DB >> 7930729

Outcomes of Bordetella pertussis infection in different age groups of an immunized population.

Q He1, M K Viljanen, S Nikkari, R Lyytikäinen, J Mertsola.   

Abstract

Outcomes of Bordetella pertussis infection were studied in 3 age groups (1-3, 4-6, and 7-15 years) during outbreaks in one day care center (n = 29) and in two elementary schools (n = 210). A total of 76 children were confirmed as having B. pertussis infection; 74 were confirmed by polymerase chain reaction (PCR) and 18 by culture. A positive PCR result was less common in children 1-3 years old than in those 4-6 (P = .006). Asymptomatic B. pertussis infection was more common in preschool children than in schoolchildren (P < .001), whereas schoolchildren presented with symptoms compatible with clinical pertussis more often than preschool children (60/210 vs. 3/29, P = .029). In the community of 12,691, the attack rate (laboratory-confirmed patients/100,000) was 317 in children < 4 years, 1838 in children 4-6 years, 2535 in children 7-15 years, and 248 in persons > 15 years. The protection provided by conventional pertussis vaccine is evidently rather short-lived, and booster vaccinations are needed to eradicate pertussis among schoolchildren and adults.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930729     DOI: 10.1093/infdis/170.4.873

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Analysis with a combination of macrorestriction endonucleases reveals a high degree of polymorphism among Bordetella pertussis isolates in eastern France.

Authors:  G Prevost; F I Freitas; P Stoessel; O Meunier; M Haubensack; H Monteil; J M Scheftel
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.

Authors:  S Esposito; T Agliardi; A Giammanco; G Faldella; A Cascio; S Bosis; O Friscia; M Clerici; N Principi
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

3.  Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.

Authors:  Daniel N Wolfe; Girish S Kirimanjeswara; Eric T Harvill
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Pertussis in rural populations of Saskatchewan (1995 to 2003): incidence, seasonality, and differences among cases.

Authors:  David Vickers; Raúl C Mainar-Jaime; Punam Pahwa
Journal:  Can J Public Health       Date:  2006 Nov-Dec

5.  Trust and the demand for autonomy may explain the low rates of immunizations among nurses.

Authors:  Orna Baron-Epel; Batya Madjar; Rami Grefat; Shmuel Rishpon
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

6.  Outcomes of Bordetella infections in vaccinated children: effects of bacterial number in the nasopharynx and patient age.

Authors:  Q He; H Arvilommi; M K Viljanen; J Mertsola
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

7.  Pertussis serodiagnosis in Belgium from 1990 to 2009.

Authors:  Muriel Vincent; Caroline Rodeghiero; Romain Eylenbosch; Yvan Mans; Jeannine Swalus-Steenhouwer; Denis Piérard; Kris Huygen; Raymond Vanhoof
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

8.  Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.

Authors:  E Grimprel; P Bégué; I Anjak; E Njamkepo; P François; N Guiso
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

9.  Nested duplex PCR to detect Bordetella pertussis and Bordetella parapertussis and its application in diagnosis of pertussis in nonmetropolitan Southeast Queensland, Australia.

Authors:  D J Farrell; G Daggard; T K Mukkur
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Infantile pertussis rediscovered in China.

Authors:  Jingmin Wang; Yonghong Yang; Jie Li; Jussi Mertsola; Heikki Arvilommi; Xuzhuang Shen; Qiushui He
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.